Business Standard

Russia asked to apply for Sputnik V vaccine trials in India via local rep

Can't let the guard down for next 2-3 months against Covid, says V K Paul of NITI Aayog; ICMR chief sas 50% vaccine efficacy acceptable in case of respiratory viruses

Sputnik V
Premium

Ruchika Chitravanshi New Delhi
India has asked the makers of Russian Covid vaccine ‘Sputnik V’ to file an application through an Indian representative for conducting trials in India, V K Paul, member (health) of NITI Aayog, told the media on Tuesday. 

He urged people to take precautions, particularly for the next two-three months, and avoid gatherings in the upcoming festive season. “They have identified who will apply on their behalf. We hope they approach the regulators soon with necessary documents,” said Paul. 

The Russian government had approached India for assistance in collaborating with Indian manufacturers, and to allow clinical trials as required by providing a regulatory

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 22 2020 | 6:51 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com